TScan Therapeutics Files 10-Q for Q1 2025
Ticker: TCRX · Form: 10-Q · Filed: May 6, 2025 · CIK: 1783328
| Field | Detail |
|---|---|
| Company | Tscan Therapeutics, Inc. (TCRX) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotechnology
TL;DR
**TScan Therapeutics Q1 2025 10-Q filed. Financials and ops update.**
AI Summary
TScan Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results and provided updates on its business operations. Key financial data and operational highlights are detailed within the filing, which was submitted on May 6, 2025.
Why It Matters
This filing provides investors with a quarterly update on TScan Therapeutics' financial health and operational progress, crucial for understanding the company's trajectory in the biotechnology sector.
Risk Assessment
Risk Level: medium — As a biotechnology company, TScan Therapeutics faces inherent risks related to clinical trials, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Period End Date (The end of the reporting quarter.)
- 20250506 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- TScan Therapeutics, Inc. (company) — Filer of the 10-Q
- 0000950170-25-063968 (other) — Accession Number for the filing
- 20250331 (date) — Period of report
- 20250506 (date) — Filing date
- 880 WINTER STREET (address) — Business and mail address
- WALTHAM, MA (location) — City and State of business address
- 02451 (postal_code) — ZIP code of business address
- 857-399-9500 (phone_number) — Business phone number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 6, 2025.
What is the company's name and Central Index Key (CIK)?
The company's name is TScan Therapeutics, Inc., and its Central Index Key is 0001783328.
What is the business address of TScan Therapeutics, Inc.?
The business address is 880 WINTER STREET, WALTHAM, MA 02451.
What is the Standard Industrial Classification (SIC) code for TScan Therapeutics, Inc.?
The SIC code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding TScan Therapeutics, Inc. (TCRX).